Bioactive Matrix for Local Bone Density Restoration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoporosis and bone cysts are inadequate, as they do not directly address the underlying causes of bone loss and fractures, with bisphosphonates being only 50% effective and surgical methods offering limited benefits, and there is a need for a more effective local treatment approach.
Innovation Solution
The use of bioactive factors such as parathyroid hormone (PTH) and bone morphogenetic proteins (BMP) incorporated into matrices for local administration at the site of bone defects, which can be formed in situ or pre-shaped for application, to promote bone regeneration and increase bone density.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If bisphosphonates are used to treat osteoporosis, then bone loss is reduced, but treatment efficacy is limited to 50% and does not directly address underlying causes
Solution Approach 1:
The patent applies local quality by transitioning from systemic bisphosphonate administration to localized delivery of bioactive factors directly at the bone defect site. This is achieved through implantable devices that release growth factors, bone morphogenetic proteins, or other bioactive molecules specifically where bone regeneration is needed, thereby increasing treatment efficacy while addressing the root cause of bone loss locally rather than systemically
Solution Approach 2:
The patent introduces intermediary devices that act as mediators between the treatment goal and the biological system. These implantable devices serve as intermediaries that deliver bioactive factors directly to the bone defect site, bypassing the limitations of systemic administration and providing controlled, targeted therapy that directly addresses the underlying causes of bone loss
2Reliability
If surgical procedures such as curettage or bone grafting are performed on bone cysts, then fracture prevention is improved, but treatment benefits remain limited and invasive
Solution Approach 1:
The patent applies parameter changes by transforming the treatment approach from mechanical surgical intervention to biochemical stimulation. Instead of physically removing cyst contents or grafting bone, the invention uses implantable devices that release bioactive factors to stimulate natural bone regeneration processes, changing the fundamental parameter of treatment mechanism from mechanical to biochemical while reducing invasiveness
Solution Approach 2:
The patent replaces mechanical surgical systems with biochemical delivery systems. Rather than using curettes, drills, or graft materials that require invasive surgery, the invention employs implantable devices that deliver growth factors and bone morphogenetic proteins to stimulate natural bone healing, substituting mechanical intervention with biochemical stimulation that is less invasive and promotes physiological repair
3Strength
If local treatment with bioactive factors is implemented, then bone density increases and bone formation is induced, but requires controlled release mechanisms
Solution Approach 1:
The patent applies preliminary action by pre-loading implantable devices with bioactive factors before implantation. The devices are prepared in advance with controlled release mechanisms that will gradually deliver the therapeutic agents over time, allowing the treatment effect to build progressively and sustain bone density improvement without requiring complex external control systems during the healing process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method effectively increases bone density and induces bone formation in areas affected by osteoporosis and bone cysts, reducing the risk of fractures and promoting structural integrity, with controlled release of bioactive factors enhancing treatment efficacy.
Implementation Method 1
The bioactive factor is released from the matrix and triggers regeneration of bone tissue locally
Data Source
AI summary
A method of local treatment of specific bone defects such as osteoporosis or bone cysts comprises the step of local administration of a formulation comprising a fusion peptide containing a first domain comprising PTH or BMP 2 or BMP 7, and a second domain comprising a covalently crosslinkable substrate domain; and a material suitable of forming a biodegradable matrix suitable for cellular growth or in-growth, wherein the fusion peptide is covalently linked to the matrix. In one embodiment, the matrix contains one or more contrast agents, and is preferably formed in the absence of a growth factor. The matrix may be used in the treatment of fluid-filled cysts such as Tarlov cysts, ovarian cysts, arachnoid cysts, aneurysmal bone cysts or hepatic cysts.